ArticleCurrent genomics2025
Analysis of Endoplasmic Reticulum Stress-Associated Proteins As Prognostic Markers In Breast Cancer.
Article in Current genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Breast cancer is a complex, heterogeneous disease that poses a significant global health risk. Both internal and external cellular stresses contribute to breast cancer progression. Endoplasmic reticulum (ER) stress is one such cellular stress response that activates intricate intracellular signaling pathways collectively known as the unfolded protein response (UPR). Maintaining protein homeostasis and regulating these pathways is essential in breast cancer progression. Methods: Using STRING and Harmonizome Reactome pathway datasets, we identified a list of UPR-associated genes. The Human Protein Atlas and UALCAN databases were used to analyze these genes as potential prognostic markers in breast cancer. Results: Three prognostic markers were identified in patients with breast cancer: FK506 binding protein 14 (FKBP14), S-phase kinase-associated protein 1 (SKP1), and Baculoviral IAP repeat containing 3 (BIRC3). Discussion: Expression levels of FKBP14, SKP1, and BIRC3 were compared to TCGA normal and GTEx data using the GEPIA2 database. Our analysis indicates that higher SKP1 expression is associated with poor overall survival and prognosis, whereas higher BIRC3 expression correlates with better prognosis and overall survival. BIRC3 protein levels are elevated in tumor tissue and increase as the tumor progresses through various stages. Additionally, the expression of these markers varies according to sex, age, ethnicity, breast cancer subtype, nodal metastasis, and menopause status. Conclusion: Overall, our study identifies that the genes involved in ER stress that are associated with breast cancer can serve as prognostic markers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.